Get started

Investment

LTIM - Getting ReadyThe chart is self explanatory. Since Nov. 21, the price has been forming a Triangular pattern. Already given a breakout of that. Since Jan. 24, A Cup & Handle pattern is formed and a breakout is seen on the charts. At present time, we can observe the retest of the both breakouts. If the price gives a bounce back from present range of 6000-5800 and sustains above, may see a bullish run upto 7000/7500 and even more. If sustains below 5600, the setup goes weak. One should mind the position size according the risk-management. The above illustration is my own view, only for learning and sharing purposes, not a trading advice in any form. All the best.
NSE:LTIMLong
by anandlive
4
Moil - Low Risk Setup CMP 334.60 on 02.11.24 The price has been corrected by around 40% from the higher levels. All important levels are marked on the charts. If crosses the area of 340-370 and sustains above, may go into a bullish phase again. targets may be 380/480 and even more. If sustains below 310 and sustains below, the setup goes weak. At present point, the risk-reward ratio is quite good. This is my view only for learning and sharing purposes, not trading advice in any form. All the best for your trading journeys.
NSE:MOILLong
by anandlive
A Healthcare Face-Off: Apollo vs. Narayana◉ Abstract India's hospital industry is growing rapidly, valued at ₹8.35 lakh cr. ($98.98 B) in 2023, with a projected CAGR of 5.8-8.0% from 2024 to 2032. Apollo Hospitals and Narayana Hrudayalaya are two leading players, with Apollo being the largest private hospital network and Narayana Hrudayalaya known for cost-effective cardiac care. Narayana Hrudayalaya appears undervalued with a P/E ratio of 33.5 and more profitable (ROCE: 27%), making it an attractive investment option. Apollo Hospitals seems overvalued with a P/E ratio of 83.4 but remains viable for strategic entry points. Both companies are poised for growth driven by increasing healthcare demands and infrastructure expansion. Read full analysis here........ ◉ Introduction The hospital industry in India is experiencing significant growth, with the market valued at approximately ₹8.35 lakh cr. ($98.98 B) in 2023. Projections indicate a robust compound annual growth rate (CAGR) of 5.8% to 8.0% from 2024 to 2032, potentially reaching between 13.87 lakh cr. and 16.33 lakh cr. ($164.4 B - $193.6 B) by 2032, depending on various market analyses. ◉ Growth Drivers of the Indian Hospital Industry ● Increased Healthcare Expenditure: ➖ Rising public and private spending on healthcare, with government health expenditure aiming for 2.5% of GDP by 2025. ➖ Expanding middle class with higher disposable incomes and greater access to health insurance. ● Technological Advancements: ➖ Adoption of healthcare technologies such as telemedicine and robotic automation, improving service delivery. ➖ National Digital Health Blueprint promoting innovations in e-health. ● Policy Support and Foreign Investment: ➖ Favourable government policies allowing 100% FDI in healthcare, attracting significant investments. ➖ Public-private partnerships enhancing healthcare access, especially in underserved areas. ● Demand for Specialized Services: ➖ Increasing incidence of lifestyle diseases driving demand for specialized healthcare. ➖ Growth in medical tourism as India becomes a preferred destination for cost-effective treatments. These factors are collectively propelling the growth of the hospital industry in India, positioning it for a promising future. ◉ Key players in the Indian hospital sector 1. Apollo Hospitals leads the sector with a market capitalization of approximately ₹98,646 Cr, establishing itself as the largest private hospital network in India. 2. Max Healthcare closely follows, boasting a market capitalization of around ₹97,820 Cr. 3. Fortis Healthcare is another key participant in the market, with a market capitalization of ₹48,249 Cr. 4. Global Health also ranks among the premier healthcare institutions, holding a market capitalization of ₹28,786 Cr. 5. Narayana Hrudayalaya is recognized for its cost-effective cardiac care services and maintains a notable market share with a market capitalization of ₹26,086 Cr. In this report, we will conduct an in-depth analysis and comparison between two of India's leading healthcare providers, Apollo Hospitals and Narayana Hrudayalaya. This comprehensive evaluation will assess their technical and fundamental aspects, ◉ Company Overviews ● Apollo Hospital NSE:APOLLOHOSP Apollo Hospitals was founded in 1983 by Dr. Prathap C Reddy, a visionary in the evolution of modern healthcare in India. As the first corporate hospital in the country, Apollo Hospitals is celebrated for leading the charge in the private healthcare transformation. Today, Apollo Hospitals stands as Asia's leading integrated healthcare services provider, boasting a strong footprint throughout the healthcare landscape. This includes a diverse range of services such as hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models. ● Narayana Hrudalaya NSE:NH Narayana Hrudayalaya Limited is involved in providing medical and healthcare services both in India and abroad. It functions through two main divisions: Medical and Healthcare Related Services, and Others. The organization is responsible for acquiring, owning, and managing a variety of healthcare facilities, including hospitals, clinics, health centres, diagnostic centres, and nursing homes, among other related operations. Its range of services encompasses cardiology, cardiac surgery, nephrology, urology, neurology, neurosurgery, endocrinology, orthopaedics, internal medicine, obstetrics, gynaecology, pediatrics, neonatology, gastroenterology, and oncology. Additionally, the company is active in the health insurance sector. Established in 2000, its headquarters is located in Bengaluru, India. ◉ Technical Analysis ● Apollo Hospitals ➖ The stock faced a significant obstacle near the 5,800 level, resulted in a steep drop. ➖ It later found support around 3,500 and rebounded. ➖ Following an extended period of consolidation, the price developed a Rounding Bottom pattern. ➖ A breakout ensued, leading to a price increase, but it encountered resistance close to 6,800, which triggered a pullback to the breakout point. ➖ Following a successful retest, the price surged past the previous high, reaching a new peak at 7,545. ➖ However, due to prevailing negative market sentiments, the price has since retraced and is currently trading just above its immediate support zone. ● Narayana Hrudalaya ➖ The stock price is overall in an uptrend. ➖ After reaching an all-time high close to the 1,445 level, the price experienced a decline and has since entered a consolidation phase. ➖ A Symmetrical Triangle pattern has formed on the chart. ➖ We expect an upward breakout from this pattern, which could lead to a significant price rally. ◉ Relative Strength ➖ The chart reveals that both Apollo and Narayana Hrudayalaya have underperformed the Nifty Healthcare index. Although Apollo has given a descent 31% return, Narayana lagged significantly, yielding a modest 17% return. In contrast, the Nifty Healthcare index delivered an impressive 41% return. ◉ Service Wise Revenue Breakdown ● Apollo Hospitals The company operates through three primary segments, each contributing significantly to its revenue. ➖ Healthcare services account for approximately 52% of total revenue, forming the largest share. ➖ The retail pharmacy business generates nearly 41% of total sales, while the retail health and diagnostics segment contributes the remaining 7%. ● Narayana Hrudalaya ➖ The company operates exclusively in the healthcare services sector, deriving all its revenue from this single segment. ◉ Revenue & Profit Analysis ● Apollo Hospitals Year-over-Year ➖ The company's fiscal year 2024 performance was marked by strong growth, with revenue reaching ₹19,059 crore, a 15% increase from ₹16,612 crore in FY23. ➖ EBITDA surged to ₹2,394 crore, up from ₹2,065 crore in FY23, while the EBITDA margin improved to 13% from 12%. Quarter-over-Quarter ➖ In the latest quarter ending September 2024, the company achieved its highest-ever sales of ₹5,589 crore, significantly up from ₹5,086 crore in June 2024. This quarter-on-quarter growth has been consistent since March 2022. ➖ EBITDA for the quarter was an impressive ₹816 crore, a 21% increase from ₹675 crore in June 2024. ➖ Diluted EPS (LTM) rose substantially to ₹83.31 from ₹72.13 in June 2024. ● Narayana Hrudalaya Year-over-Year ➖ In FY24, our company achieved remarkable sales growth, surging 11% to ₹5,018 crore from ₹4,525 crore in FY23. ➖ EBITDA soared to ₹1,173 crore, up from ₹987 crore in the same period, with an impressive EBITDA margin of 23%. Quarter-over-Quarter ➖ Our quarterly sales reached an all-time high of ₹1,400 crore in September, representing a 4% increase from ₹1,341 crore in June. ➖ Although EBITDA growth was modest, it still improved to ₹308 crore in September from ₹304 crore in June 2024. ➖ However, Diluted EPS experienced a decline, dropping to ₹38.85 from ₹39.72. ◉ Valuation ● P/E Ratio ➖ Apollo Hospitals' current P/E ratio stands at 83.4, down from its 1-year median of 107.7. However, this remains significantly above the industry average of 56.9, indicating overvaluation. ➖ In contrast, Narayana Hrudalaya's P/E ratio of 33.5 is slightly above its 1-year median of 32.8 and substantially below the industry average, suggesting undervaluation. ● P/B Ratio ➖ Apollo's P/B ratio of 13.15 indicates considerable overvaluation compared to the industry average of 7.18. ➖ Narayana Hrudalaya's P/B ratio of 8.14 also suggests overvaluation, albeit to a lesser extent. ● PEG Ratio ➖ Narayana's PEG ratio of 0.49 positions it as an attractive investment opportunity, especially when compared to Apollo's considerably higher PEG of 2.43. ◉ Profitability Analysis ➖ Apollo Hospitals ROCE - 15% in FY24 ➖ Narayana Hrudalaya ROCE - 27% in FY24 The significant difference in ROCE between the two healthcare giants underscores Narayana Hrudalaya's superior profitability. Narayana's impressive ROCE of 27% demonstrates its ability to efficiently utilize its total capital, comprising both equity and debt, to generate substantially higher returns. ◉ Cash Flow Analysis ➖ Apollo Hospitals has demonstrated impressive growth in its operating cash flow, surging 39% to ₹1,920 crore in FY24 from ₹1,377 crore in FY23. This robust growth underscores the company's efficiency in converting profits into cash, highlighting its strong financial health and liquidity position. ➖ In contrast, Narayana Hrudalaya has shown sluggishness in turning profits into cash, with its operating cash flow declining 2% to ₹1,067 crore in FY24 from ₹1,085 crore in FY23. ◉ Debt Analysis ➖ Apollo Hospitals' debt stands at ₹7,371 crore, resulting in a debt-to-equity ratio of 0.98, which, although relatively high, is not alarming. However, the company's low interest coverage ratio of 4.69 raises concerns about its ability to service its debt. This vulnerability may complicate repayment of borrowed loans, potentially straining Apollo's financial stability. ➖ In contrast, Narayana Hrudalaya's debt of ₹1,703 crore and debt-to-equity ratio of 0.53 indicate robust financial health. Furthermore, its impressive interest coverage ratio of 8.34 suggests the company is well-positioned to manage its debt obligations, ensuring greater financial flexibility and stability. ◉ Shareholding Pattern ● Apollo Hospitals ➖ In the September quarter, Foreign Institutional Investors (FIIs) increased their stake in Apollo Hospitals to 45.37%, up from the previous quarter. ➖ Conversely, Domestic Institutional Investors (DIIs) reduced their holdings to 19.94%, a significant decrease from 24.77% in the last quarter. ● Narayana Hrudalaya ➖ In contrast, Narayana Hrudalaya witnessed a decline in institutional investor holdings. FIIs reduced their stake to 9.69%, down from 10% in the previous quarter. ➖ Domestic Institutional Investors (DIIs) also decreased their holdings to 7.9%, down from 8.22% in the June quarter. ◉ Conclusion Following a comprehensive analysis of both technical and fundamental aspects, we conclude that Narayana Hrudalaya appears to be favorably positioned from a valuation perspective, presenting an attractive investment opportunity. However, this does not diminish Apollo Hospitals' potential. Although the stock currently appears overvalued, investors can consider accumulating shares during dips, making it a viable option for those seeking strategic entry points. The healthcare sector's promising growth trajectory, fueled by rising healthcare demands and infrastructure expansion, positions both companies for potentially excellent returns in the near future.
NSE:APOLLOHOSPLong
by GoodluckCapital
2
NIFTY... KEEP INVESTING...Guys... I am sharing my view on the Elliot waves in Nifty. The bullish pattern is intact. We are currently in the 3rd primary wave. Of the five intermediate waves in the primary wave 3, nifty is right now in wave (4) correction. A quick and rapid wave (5) is likely to start at the end of wave 4. Though Nifty is at 200 EMA right now, I feel the strong support zone is around 22700 levels. I won't be surprised if Nifty can fall around 800 points from here. Keep investing in parts and add more when Nifty goes below 23000. The market is always right..! Trade with appropriate stop-loss.
NSE:NIFTYLong
by Stock-Holmes
Nifty.23300 on the cards??Nifty closed right at an important support. Now the likelihood of Nifty pulling back to 200 DMA( around 23550 range) and 23300 level is high. 23300 region have a trendline support as well, if we did not get any reversal from there and the trendline is broken then possibility of Nifty going to 21800 will increase. As of now, no point in attempting to find reversal. No point in assuming levels. We could very well get a reversal from current level or a pull back to 200 DMA. No telling right now. Wait and watch market. Take it day by day, bits by bits Do not assume it will hit 21800-21k 20k 18K. -Stocks trading below 200 DMA is roughly 50 % -Stocks trading below 50 DMA is close to 80% -Most of the stocks exhibiting LH-LL -Majority sectors forming LH-LL. We need a solid confirmation before attempting any reversal trades. This is just my view, please do not make a decision without consulting your financial advisor.
NSE:NIFTY
by sagartharayil
3
Motison Aiming for a base breakout!#Tradeideas #motison- After the split the stock is setting up and trying to break out of base. Watch the PA closely. Safe traders wait for a close above 34. -SL is deep around 15%. So position size accordingly. - Not a time for big bets yet. - Do your due diligence and protect your capital, please do not be complacent. Trade Safe! Market Cap---₹ 3,244 Cr. Current Price--₹ 33.0 Stock P/E---85.6 ROCE---16.6 % ROE---13.9 % Face Value---₹ 1.00
NSE:MOTISONSLong
by sagartharayil
Cello World - PositionalIn the last few months, the stock had been traveling in a rising wedge pattern. Recently breached the channel in downside. At present trying to enter the channel again, after taking support at the 860-870 zone. That has been a good support level in the recent sessions. If crosses 930, with good volumes and sustains the momentum, further targets may be 1000/ 1120. If sustains below 860, the setup will go weak. This illustration is only my view, only for learning and sharing purposes, not a piece of trading advice in any form. All the best.
NSE:CELLOLong
by anandlive
JAIPRAKSH POWER VENTURENSE:JPPOWER fundamental looks good and below scenario might be possible Technically stock is consolidating between 17 to 21 from last 52 weeks and recently it breaks 21 level. So I will make long position after breakout of 52 weeks which is 24 (if sustain) with stoploss below 21 (if sustain). No position until 24 has been crossed. NOTE - This is my opinion not recommendation. So do your own analysis and make positions accordingly. Ping me personally if you have long term horizon
NSE:JPPOWERLong
by RAVII_TIWARII
IPCA Lab - Observing Buy SetupCMP 1361 on 09.08.24 The above weekly chart shows that the price has formed a cup & handle pattern in the last 2 years. If this pattern continues we can expect a breakout on the charts. MACD is showing a likely crossover too. Possible targets may be 1600/1800 or even more. As long as it sustains above 1300, this setup remains relevant. Decide your exit levels according to your position sizing and risk-management. This illustration is only for learning and sharing purposes, not a piece of trading advice in any form. All the best.
NSE:IPCALABLong
by anandlive
2
Navin Fluorine - Positional SetupThe chart shows the possible supports and resistances. At present, the price is about to cross a predefined resistance area around 3450-3500. If crosses the zone and picks some momentum, we may see upper targets according to the setup. Also, the gap area upside is to be filled in due time, of course in a bullish phase. If sustains above 3500, may go to 4000/4200 or even more. If sustains below 3200, this setup will go weak. Decide your entry and exit levels and position size in accordance with your risk management. All this illustration is only my view, just for learning and sharing purposes, not trading advice in any form. All the best.
NSE:NAVINFLUORLong
by anandlive
2
Indiamart - Keep On WatchCMP - 2930 on 27.09.24 Since January 24, the stock has formed a Cup & Handle-like pattern. It is now retesting the immediate support, which is around 2900-2950. If picks a bullish momentum and gives breakout of C & H pattern. It may go to 3650/ 4100+. However, the breakout level is above 3400 but the current price is a good place for an early entry with a more favorable risk-reward ratio. Considering risk management, one has to choose the entry-level and position size wisely. If the price sustains below 2620, This setup loses significance. Trade wisely and calmly. The above Illustration is only for educational and sharing purposes, not a trading recommendation in any form. All the best.
NSE:INDIAMARTLong
by anandlive
4
Bajaj Hind SugarBajaj Hind Sugar best opportunity investment Sugar Manufacturing: BHSL is a major producer of sugar in India. It has a large sugarcane crushing capacity of 136,000 tonnes crushed per day (TCD). The company produces sugar in different sizes and grades, such as large, medium, and small. Ethanol Production: BHSL is also a leading manufacturer of ethanol. It has six distilleries with a capacity to produce 800 kilo liters per day (KLPD) of industrial alcohol. Power Generation: The company generates power from bagasse, a byproduct of sugarcane crushing. It owns 14 co-generation plants with a total power generating capacity of 449 MW. Byproducts: BHSL produces various byproducts from its manufacturing processes, including molasses, bagasse, fly ash, press mud, and bio-compost/bio-manure products. Investor Relations: BHSL remains committed to protecting investor interests through strong financial performance and profitability. The company consistently works on enhancing its operational and financial efficiencies.
NSE:BAJAJHINDLong
by mrsameofficial
Bajaj Hind SugarBajaj Hind Sugar best opportunity investment Sugar Manufacturing: BHSL is a major producer of sugar in India. It has a large sugarcane crushing capacity of 136,000 tonnes crushed per day (TCD). The company produces sugar in different sizes and grades, such as large, medium, and small. Ethanol Production: BHSL is also a leading manufacturer of ethanol. It has six distilleries with a capacity to produce 800 kilo liters per day (KLPD) of industrial alcohol. Power Generation: The company generates power from bagasse, a byproduct of sugarcane crushing. It owns 14 co-generation plants with a total power generating capacity of 449 MW. Byproducts: BHSL produces various byproducts from its manufacturing processes, including molasses, bagasse, fly ash, press mud, and bio-compost/bio-manure products. Investor Relations: BHSL remains committed to protecting investor interests through strong financial performance and profitability. The company consistently works on enhancing its operational and financial efficiencies.
NSE:BAJAJHINDLong
by mrsameofficial
Mahindra & Mahindra update 500 pointsmahindra and mahindra reached 500+ points from given level 📌 Please support me with your likes 🤞🏻 and comments 💬 to motivate me to share more analysis with you and share your any opinion about the possible trend of this chart with me ! Best Regards , Davis 🥰 Hit the like 🤞🏻 button to !! Motive some energy !!🥇 📌 Note : ⨻ Check the live market updates and analysis yourself before buy 📈🔺 or sell 📉🔻 ⨺ Am not giving any advisory or signals its just my idea for upgrade my knowledge 📚 in trading ⨹ This is my pre and post market analysis to improve my trading journey 🚀 ⨂ Am Not suggesting anyone to buy or sell ❌ am just giving my views 👀 ⫸ You are responsible for your trading ✅ not me ❌ ⫷ HAPPY TRADING 🥰
NSE:M&M
by TRADING_MASTER_DAVIS
long term investment/tradejust like traders do analysis on daily weekly time frame for short term,likewise ihave done my analysis on monthly and three month tf for this stock. firstly, clearing basic analysis of globus is that we can see an nice flag pattern breaking out on a monthly time frame. secondly,wedge falling can be seen on monthly if you observe closely that too with good volumes bursting in and an support of 21 ema bith on monthly and three month time frame which makes my analysis more strong to belive if my analysis doesnt go wrong and history repeats itself we can see globus booming till levels of 4000 in upcoming years,since market doesnt follow our emotions we carry an stoploss which in our case is below levels of 860 on monthly close apart from technicals globus belong to alcohol sector which is evergreen and is going to grow at an decent rate one can easily trust on the above sector for an long term i will request to all those people who have gone through my analysis,thank you for reading and do like follow me for such content. THE ABOVE POST IS ONLY FOR EDUCATIONAL PURPOSE AND NOT AN RECOMMEND TO BUY AND SELL,PLEASE CONSULT YOUR FINANCIAL ADVISOR BEACUSE MONEY IS PRECIOUS DONT TAKE TRADES BLINDLY WITH HALF KNOWELDGE.
NSE:GLOBUSSPRLong
by rohitrc250
copper next movecopper can make small correction for fill FVG on down side for make uptrend 📌 Please support me with your likes 🤞🏻 and comments 💬 to motivate me to share more analysis with you and share your any opinion about the possible trend of this chart with me ! Best Regards , Davis 🥰 Hit the like 🤞🏻 button to !! Motive some energy !!🥇 📌 Note : ⨻ Check the live market updates and analysis yourself before buy 📈🔺 or sell 📉🔻 ⨺ Am not giving any advisory or signals its just my idea for upgrade my knowledge 📚 in trading ⨹ This is my pre and post market analysis to improve my trading journey 🚀 ⨂ Am Not suggesting anyone to buy or sell ❌ am just giving my views 👀 ⫸ You are responsible for your trading ✅ not me ❌ ⫷ HAPPY TRADING 🥰
MCX:COPPER1!
by TRADING_MASTER_DAVIS